# Safety and Immunogenicity of HIL-214 With Routine Pediatric Vaccines

> **NCT05836012** · PHASE2,PHASE3 · COMPLETED · sponsor: **HilleVax** · enrollment: 329 (actual)

## Conditions studied

- Gastroenteritis

## Interventions

- **BIOLOGICAL:** HIL-214
- **BIOLOGICAL:** Placebo

## Key facts

- **NCT ID:** NCT05836012
- **Lead sponsor:** HilleVax
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2023-06-10
- **Primary completion:** 2024-01-19
- **Final completion:** 2024-07-08
- **Target enrollment:** 329 (ACTUAL)
- **Last updated:** 2025-03-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05836012

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05836012, "Safety and Immunogenicity of HIL-214 With Routine Pediatric Vaccines". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT05836012. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*